These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1891538)

  • 21. Treatment of paruresis with in vivo desensitization: a case report.
    McCracken LM; Larkin KT
    J Behav Ther Exp Psychiatry; 1991 Mar; 22(1):57-62. PubMed ID: 1680884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
    Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenelzine and atenolol in social phobia.
    Liebowitz MR; Schneier F; Campeas R; Gorman J; Fyer A; Hollander E; Hatterer J; Papp L
    Psychopharmacol Bull; 1990; 26(1):123-5. PubMed ID: 2196620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychogenic urinary retention in a child.
    Borzyskowski M; Saxton HM
    AJR Am J Roentgenol; 1992 Sep; 159(3):677-8. PubMed ID: 1503054
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
    Liebowitz MR; Gorman JM; Fyer AJ; Campeas R; Levin AP; Sandberg D; Hollander E; Papp L; Goetz D
    J Clin Psychiatry; 1988 Jul; 49(7):252-7. PubMed ID: 3292516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
    Beil M; Ulmer WT
    Arzneimittelforschung; 1977 Feb; 27(2):419-22. PubMed ID: 324487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
    Aberg H; Hedstrand H; Wetterberg L; Ross SB
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):15-8. PubMed ID: 1150360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of atenolol and propranolol in labile hypertension.
    González-Gómez A; Pérez-Medina T; Gamio-Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1979; 21(3):202-7. PubMed ID: 535405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute urinary retention of psychogenic cause in a girl].
    Caffaratti J; Pérez Rodríguez S; Garat JM; Farré L
    Actas Urol Esp; 1993 Jun; 17(6):367-70. PubMed ID: 8368103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paruresis: a secret phobia.
    Smith A
    Nurs Times; 2006 May 9-15; 102(19):44-5. PubMed ID: 16711289
    [No Abstract]   [Full Text] [Related]  

  • 33. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
    Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery.
    Lamb RK; Prabhakar G; Thorpe JA; Smith S; Norton R; Dyde JA
    Eur Heart J; 1988 Jan; 9(1):32-6. PubMed ID: 3257915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].
    de la Sierra A
    Med Clin (Barc); 1999 Jun; 113(2):41-5. PubMed ID: 10425617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The renin-angiotensin system and the antihypertensive effect of atenolol in man.
    Mimran A; Deschodt G; Fourcade J; Barjon P
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):100-7. PubMed ID: 526065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atenolol-induced cutaneous vasculitis.
    Wolf R; Ophir J; Elman M; Krakowski A
    Cutis; 1989 Mar; 43(3):231-3. PubMed ID: 2523289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.